Alberto Sola-Leyva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alberto Sola-Leyva has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Andres Salumets
University of Tartu
10 shared publications - Maria Paz Carrasco
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, 18071 Granada, Spain
9 shared publications - Apostol Apostolov
Division of Obstetrics and Gynecology, Department of Clinical Science Intervention and Technology, Karolinska Institute Huddinge Stockholm Sweden
8 shared publications - Concepcion Jimenez-Lopez
Department of Microbiology, University of Granada, 18071 Granada, Spain
7 shared publications - Guillermo Ramon Iglesias
NanoMag Lab, Department of Applied Physics, Faculty of Science, University of Granada, Edificio I+D Josefina Castro, Av. de Madrid, 28, 18012 Granada, Spain
7 shared publications - Ylenia Jabalera
Department of Microbiology, Faculty of Sciences, University of Granada, 18071 Granada, Spain
7 shared publications
Latest Publications
- Open Access
Non-invasive Transcriptomic Cell Profiling of the Human Endometrium with Generative Deep Learning
Background: Delineating the cellular origins of extracellular vesicles (EVs) enables the detection of clinically relevant changes in dynamic and complex tissues, such as the endometrium, which are not characterizable through single biomarker assays. Transcriptome deconvolution into cellular composition using deep learning methods provides a means to explore this complexity. However, such computational methods have not been previously applied to EV bulk transcriptomes, and their efficacy in profiling EV population changes and concordance to tissue throughout the menstrual cycle remains unknown. Methods: This observational cross-sectional study utilized a deconvolutional generative deep learning algorithm, BulkTrajBlend, trained on a comprehensive human endometrial single-cell RNA sequencing (scRNA-seq) atlas. The model was applied to deconvolve paired bulk transcriptomes from endometrial tissue and uterine fluid EVs (UF-EVs) across the proliferative (P, n=4), early-secretory (ES, n=5), mid-secretory (MS, n=5), and late-secretory (LS, n=5) phases from healthy, fertile women. To validate generalizability, independent UF-EV datasets (ES, n=12; MS, n=12) obtained via different laboratory protocols were included. Deconvolved pseudo-single-cell (pSC) profiles from UF-EV data were subsequently integrated with Visium spatial transcriptomics slides of human endometrium (P, n=2; MS, n=4; ES, n=2). Results: We developed a foundation model-based approach utilizing self-supervised learning to determine the cellular origin of EVs from their transcriptomic profiles. By mapping the generated pSC profiles to spatial transcriptomic data, we evaluated spatial origins of EVs. The statistical analysis demonstrated that UF-EV transcriptome deconvolution reflects the dynamic changes in the cellular composition of endometrial tissue across the menstrual cycle phases. The ability to distinguish accurately between proliferative and decidualizing menstrual cycle phases (ROC-AUC = 0.98) using cellular profile of deconvoluted UF-Evs transcriptome enables non-invasive profiling of endometrial tissue. Conclusions: Our findings indicate the feasibility of determining endometrial tissue cellular composition using UF-EV transcriptomics. This methodology enables refined, non-invasive endometrial testing, avoiding invasive biopsy procedures. Based on deconvolution results, we are able to correlate UF-EV content to tissue, and distinguish between menstrual cycle phases. These results build toward a multifactorial screening method for abnormalities within the endometrium.
Open AccessNon-invasive Transcriptomic Cell Profiling of the Human Endometrium with Generative Deep Learning
Background: Delineating the cellular origins of extracellular vesicles (EVs) enables the detection of clinically relevant changes in dynamic and complex tissues, such as the endometrium, which are not characterizable through single biomarker assays. Transcriptome deconvolution into cellular composition using deep learning methods provides a means to explore this complexity. However, such computational methods have not been previously applied to EV bulk transcriptomes, and their efficacy in profiling EV population changes and concordance to tissue throughout the menstrual cycle remains unknown. Methods: This observational cross-sectional study utilized a deconvolutional generative deep learning algorithm, BulkTrajBlend, trained on a comprehensive human endometrial single-cell RNA sequencing (scRNA-seq) atlas. The model was applied to deconvolve paired bulk transcriptomes from endometrial tissue and uterine fluid EVs (UF-EVs) across the proliferative (P, n=4), early-secretory (ES, n=5), mid-secretory (MS, n=5), and late-secretory (LS, n=5) phases from healthy, fertile women. To validate generalizability, independent UF-EV datasets (ES, n=12; MS, n=12) obtained via different laboratory protocols were included. Deconvolved pseudo-single-cell (pSC) profiles from UF-EV data were subsequently integrated with Visium spatial transcriptomics slides of human endometrium (P, n=2; MS, n=4; ES, n=2). Results: We developed a foundation model-based approach utilizing self-supervised learning to determine the cellular origin of EVs from their transcriptomic profiles. By mapping the generated pSC profiles to spatial transcriptomic data, we evaluated spatial origins of EVs. The statistical analysis demonstrated that UF-EV transcriptome deconvolution reflects the dynamic changes in the cellular composition of endometrial tissue across the menstrual cycle phases. The ability to distinguish accurately between proliferative and decidualizing menstrual cycle phases (ROC-AUC = 0.98) using cellular profile of deconvoluted UF-Evs transcriptome enables non-invasive profiling of endometrial tissue. Conclusions: Our findings indicate the feasibility of determining endometrial tissue cellular composition using UF-EV transcriptomics. This methodology enables refined, non-invasive endometrial testing, avoiding invasive biopsy procedures. Based on deconvolution results, we are able to correlate UF-EV content to tissue, and distinguish between menstrual cycle phases. These results build toward a multifactorial screening method for abnormalities within the endometrium.
- Open Access
- 15 May 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (5) , e70296
Bacterial Extracellular Vesicles: New Hype or Hope to Explain Reproductive Host–Microbiota Interactions
Rapid advances in microbiome research are transforming our understanding of human health and disease, with growing focus on the female reproductive tract as a critical but understudied niche. Evidence for a local microbiome largely derives from bacterial nucleic acid detection; however, the biological relevance of these signals remains debated, with whether they reflect viable microbial communities, transient colonisation, or mere microbial remnants with immunomodulatory effects. Bacterial extracellular vesicles (BEVs) have emerged as pivotal mediators of host–microbiota crosstalk. Their small size enables them to traverse tissue barriers, enter systemic circulation and access barrier‐protected anatomical sites like the placenta, thereby extending their biological reach beyond the site of origin. Although BEVs have been extensively characterised in the context of gastrointestinal, respiratory and systemic diseases, their relevance within the reproductive tract remains insufficiently defined. Understanding whether BEVs contribute to processes such as endometrial receptivity, gamete interaction, embryo implantation and immune tolerance in early pregnancy may reveal novel mechanisms of reproductive physiology and pathology. Furthermore, unravelling the role of BEVs could help resolve the ongoing debate regarding the existence of a functional upper reproductive tract (URT) microbiota, reframing it in terms of microbial activity rather than microbial presence alone. This review synthesises the limited but growing body of evidence on BEVs in the reproductive tract, with a particular emphasis on their potential influence on female fertility and early pregnancy outcomes. We also outline the major methodological challenges, including the discrimination of BEVs from host‐derived extracellular vesicles (EVs), the technical limitations of current detection approaches and the risk of contamination in low‐biomass environments that complicate research in this field. Finally, we highlight conceptual frameworks and future research directions needed to establish BEVs as important players in reproductive biology and to harness their diagnostic and therapeutic potential in reproductive medicine.
- 15 May 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (5) , e70296
Open AccessBacterial Extracellular Vesicles: New Hype or Hope to Explain Reproductive Host–Microbiota Interactions
Rapid advances in microbiome research are transforming our understanding of human health and disease, with growing focus on the female reproductive tract as a critical but understudied niche. Evidence for a local microbiome largely derives from bacterial nucleic acid detection; however, the biological relevance of these signals remains debated, with whether they reflect viable microbial communities, transient colonisation, or mere microbial remnants with immunomodulatory effects. Bacterial extracellular vesicles (BEVs) have emerged as pivotal mediators of host–microbiota crosstalk. Their small size enables them to traverse tissue barriers, enter systemic circulation and access barrier‐protected anatomical sites like the placenta, thereby extending their biological reach beyond the site of origin. Although BEVs have been extensively characterised in the context of gastrointestinal, respiratory and systemic diseases, their relevance within the reproductive tract remains insufficiently defined. Understanding whether BEVs contribute to processes such as endometrial receptivity, gamete interaction, embryo implantation and immune tolerance in early pregnancy may reveal novel mechanisms of reproductive physiology and pathology. Furthermore, unravelling the role of BEVs could help resolve the ongoing debate regarding the existence of a functional upper reproductive tract (URT) microbiota, reframing it in terms of microbial activity rather than microbial presence alone. This review synthesises the limited but growing body of evidence on BEVs in the reproductive tract, with a particular emphasis on their potential influence on female fertility and early pregnancy outcomes. We also outline the major methodological challenges, including the discrimination of BEVs from host‐derived extracellular vesicles (EVs), the technical limitations of current detection approaches and the risk of contamination in low‐biomass environments that complicate research in this field. Finally, we highlight conceptual frameworks and future research directions needed to establish BEVs as important players in reproductive biology and to harness their diagnostic and therapeutic potential in reproductive medicine.
- Open Access
Functional profiling of human chorionic gonadotrophin in embryo peri- and post-implantation in vitro models
Human embryo implantation, occurring approximately one week after fertilization, remains poorly understood due to ethical and technical limitations of in vivo investigation. To overcome these barriers, and model this critical developmental event, encompassing peri- and early post-implantation stages, we used an in vitro embryo attachment model composed of donor-derived endometrial epithelial cells forming an open-faced endometrial layer (OFEL) and human stem cell-derived blastoids recapitulating human day 5 blastocysts in peri-implantation model. Following attachment, developmental progression was further investigated on laminin-coated substrates to capture early post-implantation dynamics. Despite its central role as the primary endocrine signal of early pregnancy, human chorionic gonadotropin (hCG) remains largely uncharacterized in this context. Here, we describe the transcriptomic profile of blastoid–endometrial co-cultures relative to OFEL alone, identifying CGA and CGB3/5/8 as among the most strongly upregulated genes following blastoid attachment to hormonally stimulated OFEL. Consistent with these findings, immunoassays and luteinizing hormone/choriogonadotropin receptor (LHCGR) activation assays of conditioned media confirmed the secretion of heterodimeric, biologically active hCG and its free subunits in co-cultures, but not in endometrial layers alone. Notably, the hyperglycosylated hCG heterodimer was the predominant isoform detected. Co-culture with the endometrial component significantly increased hCG secretion compared with blastoids cultured alone, an effect further enhanced by hormonal priming in the peri-implantation model. Collectively, these findings indicate that a hormonally primed endometrial environment not only promotes blastoid attachment but also amplifies embryonic hCG production and bioactivity, underscoring the importance of maternal endocrine cues in early embryo-endometrium communication. Furthermore, our peri-and early post-implantation models recapitulate key aspects of reciprocal endocrine signaling between embryonic and endometrial tissues, providing a tractable experimental framework to investigate embryo–endometrium crosstalk.
Open AccessFunctional profiling of human chorionic gonadotrophin in embryo peri- and post-implantation in vitro models
Human embryo implantation, occurring approximately one week after fertilization, remains poorly understood due to ethical and technical limitations of in vivo investigation. To overcome these barriers, and model this critical developmental event, encompassing peri- and early post-implantation stages, we used an in vitro embryo attachment model composed of donor-derived endometrial epithelial cells forming an open-faced endometrial layer (OFEL) and human stem cell-derived blastoids recapitulating human day 5 blastocysts in peri-implantation model. Following attachment, developmental progression was further investigated on laminin-coated substrates to capture early post-implantation dynamics. Despite its central role as the primary endocrine signal of early pregnancy, human chorionic gonadotropin (hCG) remains largely uncharacterized in this context. Here, we describe the transcriptomic profile of blastoid–endometrial co-cultures relative to OFEL alone, identifying CGA and CGB3/5/8 as among the most strongly upregulated genes following blastoid attachment to hormonally stimulated OFEL. Consistent with these findings, immunoassays and luteinizing hormone/choriogonadotropin receptor (LHCGR) activation assays of conditioned media confirmed the secretion of heterodimeric, biologically active hCG and its free subunits in co-cultures, but not in endometrial layers alone. Notably, the hyperglycosylated hCG heterodimer was the predominant isoform detected. Co-culture with the endometrial component significantly increased hCG secretion compared with blastoids cultured alone, an effect further enhanced by hormonal priming in the peri-implantation model. Collectively, these findings indicate that a hormonally primed endometrial environment not only promotes blastoid attachment but also amplifies embryonic hCG production and bioactivity, underscoring the importance of maternal endocrine cues in early embryo-endometrium communication. Furthermore, our peri-and early post-implantation models recapitulate key aspects of reciprocal endocrine signaling between embryonic and endometrial tissues, providing a tractable experimental framework to investigate embryo–endometrium crosstalk.
- Open Access
Semaglutide alters the human embryo–endometrium interface
The use of semaglutide (SE), a glucagon-like peptide-1 receptor agonist (GLP-1RA) with glucose-lowering and weight-loss effects, has risen rapidly, particularly among women of reproductive age. While preclinical studies suggest benefits for ovarian function via the hypothalamic–pituitary–ovarian axis, its impact on the endometrial–embryo interface remains unclear. Here, we show that GLP-1R is dynamically expressed in fertile human endometrium, restricted to epithelial cells and markedly upregulated during the mid-secretory phase of the menstrual cycle. In a preclinical model of endometrial epithelial organoids, SE at physiological concentrations activates intracellular cAMP signaling, enhances epithelial metabolism, and upregulates receptivity markers without steroid hormone priming, whereas higher concentrations modestly reduce expression of a key receptivity marker PAEP /glycodelin and shift metabolism towards oxidative phosphorylation. By contrast, in stromal cells lacking detectable GLP-1R, SE disrupts decidualization, induces endoplasmic reticulum stress and suppresses cell-cycle at G2/M phase. Human embryo models, blastoids, expressed GLP-1R and underwent concordant SE-mediated transcriptional remodeling in epiblast and trophectoderm lineages, encompassing changes in metabolism and epigenetic regulation, but without shifts in lineage proportions. Notably, SE increased blastoid attachment to the endometrial epithelium in the absence of exogenous steroid hormones, suggesting enhanced epithelial–embryo interaction. Together, these findings reveal a compartment-specific mismatch, as SE augments epithelial and embryonic metabolic activity but compromises stromal support for implantation, with potential consequences for implantation due to stromal dysfunction.
Open AccessSemaglutide alters the human embryo–endometrium interface
The use of semaglutide (SE), a glucagon-like peptide-1 receptor agonist (GLP-1RA) with glucose-lowering and weight-loss effects, has risen rapidly, particularly among women of reproductive age. While preclinical studies suggest benefits for ovarian function via the hypothalamic–pituitary–ovarian axis, its impact on the endometrial–embryo interface remains unclear. Here, we show that GLP-1R is dynamically expressed in fertile human endometrium, restricted to epithelial cells and markedly upregulated during the mid-secretory phase of the menstrual cycle. In a preclinical model of endometrial epithelial organoids, SE at physiological concentrations activates intracellular cAMP signaling, enhances epithelial metabolism, and upregulates receptivity markers without steroid hormone priming, whereas higher concentrations modestly reduce expression of a key receptivity marker PAEP /glycodelin and shift metabolism towards oxidative phosphorylation. By contrast, in stromal cells lacking detectable GLP-1R, SE disrupts decidualization, induces endoplasmic reticulum stress and suppresses cell-cycle at G2/M phase. Human embryo models, blastoids, expressed GLP-1R and underwent concordant SE-mediated transcriptional remodeling in epiblast and trophectoderm lineages, encompassing changes in metabolism and epigenetic regulation, but without shifts in lineage proportions. Notably, SE increased blastoid attachment to the endometrial epithelium in the absence of exogenous steroid hormones, suggesting enhanced epithelial–embryo interaction. Together, these findings reveal a compartment-specific mismatch, as SE augments epithelial and embryonic metabolic activity but compromises stromal support for implantation, with potential consequences for implantation due to stromal dysfunction.
- Open Access
- 19 February 2026
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 72 (1) , 131-148
Aberrant epithelial differentiation may contribute to endometrial polyp formation: insights from single-cell analysis
Endometrial polyps (EPs) are benign overgrowths of the endometrium causing abnormal uterine bleeding and infertility. Despite their clinical significance, the molecular mechanisms underlying their development and recurrence remain poorly understood, warranting comprehensive transcriptomic investigation. We hypothesized that transcriptomic differences, particularly at the single-cell level as revealed through cellular trajectory analysis, distinguish EPs from adjacent endometrium. To investigate this, paired EP and adjacent endometrium (adEN) samples were collected from 12 women undergoing hysteroscopic polypectomy (proliferative phase, n = 9; secretory phase, n = 3) and analyzed using bulk and single-cell RNA sequencing (scRNA-seq). Bulk RNA-seq revealed high transcriptional similarity between EPs and adENs, with only a few differentially expressed genes (FDR < 0.05) in proliferative-phase EPs, including upregulation of KMT2B and DLEC1 and downregulation of COL9A1 and RAB3C, potentially reflecting epigenetic regulation and protective mechanisms against tumorigenesis. scRNA-seq identified eight major cell clusters namely stromal, epithelial, endothelial, immune, perivascular, macrophage, B cell, and ciliated populations in both tissues. Pseudotime analysis revealed a mid-transcriptional arrest and enrichment of MECOM/EYA2-positive intermediate epithelial states in EPs, in contrast to the late, mature epithelial stage seen in the adENs. This aberrant epithelial maturation may be associated with impaired perivascular and endothelial differentiation, potentially contributing to defective vascular remodeling and polyp persistence. In conclusion, while EPs exhibit global transcriptomic similarity to adENs, single-cell and pseudotime analyses suggest subtle but significant disruptions in epithelial differentiation and vascular remodeling that might be involved in EPs development. Study limitations include scRNA-seq restricted to the proliferative phase, which may limit generalizability. Nevertheless, future functional studies using primary epithelial organoids derived from EPs may provide a physiologically relevant model to evaluate targeted therapeutic strategies including hormonal interventions with potential applications in infertility management.
- 19 February 2026
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 72 (1) , 131-148
Open AccessAberrant epithelial differentiation may contribute to endometrial polyp formation: insights from single-cell analysis
Endometrial polyps (EPs) are benign overgrowths of the endometrium causing abnormal uterine bleeding and infertility. Despite their clinical significance, the molecular mechanisms underlying their development and recurrence remain poorly understood, warranting comprehensive transcriptomic investigation. We hypothesized that transcriptomic differences, particularly at the single-cell level as revealed through cellular trajectory analysis, distinguish EPs from adjacent endometrium. To investigate this, paired EP and adjacent endometrium (adEN) samples were collected from 12 women undergoing hysteroscopic polypectomy (proliferative phase, n = 9; secretory phase, n = 3) and analyzed using bulk and single-cell RNA sequencing (scRNA-seq). Bulk RNA-seq revealed high transcriptional similarity between EPs and adENs, with only a few differentially expressed genes (FDR < 0.05) in proliferative-phase EPs, including upregulation of KMT2B and DLEC1 and downregulation of COL9A1 and RAB3C, potentially reflecting epigenetic regulation and protective mechanisms against tumorigenesis. scRNA-seq identified eight major cell clusters namely stromal, epithelial, endothelial, immune, perivascular, macrophage, B cell, and ciliated populations in both tissues. Pseudotime analysis revealed a mid-transcriptional arrest and enrichment of MECOM/EYA2-positive intermediate epithelial states in EPs, in contrast to the late, mature epithelial stage seen in the adENs. This aberrant epithelial maturation may be associated with impaired perivascular and endothelial differentiation, potentially contributing to defective vascular remodeling and polyp persistence. In conclusion, while EPs exhibit global transcriptomic similarity to adENs, single-cell and pseudotime analyses suggest subtle but significant disruptions in epithelial differentiation and vascular remodeling that might be involved in EPs development. Study limitations include scRNA-seq restricted to the proliferative phase, which may limit generalizability. Nevertheless, future functional studies using primary epithelial organoids derived from EPs may provide a physiologically relevant model to evaluate targeted therapeutic strategies including hormonal interventions with potential applications in infertility management.
- Top Cited PapersOpen Access
- 6 January 2026
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (1)
Comprehensive 16S rRNA gene sequencing and meta-transcriptomic analyses of the female reproductive tract microbiota: two molecular profiles with different messages
STUDY QUESTION: Does the analysis of endometrial microbes provide the same information when using DNA or RNA sequencing-based techniques? SUMMARY ANSWER: DNA vs. RNA-based microbial analysis techniques demonstrated significant microbial compositional differences and lack of transcriptionally active Lactobacilli in the endometrium. WHAT IS KNOWN ALREADY: Our understanding of the endometrial microbiome is primarily based on DNA-based 16S rRNA gene profiling, but DNA detection does not imply the presence of living microbes. While this method is cost-effective and widely used, it has notable limitations, including the underestimation of microbial diversity, abundance, and functionality, as well as limited species-level resolution. While the microbiome reflects DNA-based characterisation, the microbiota more precisely captures metabolically active communities. In this context, meta-transcriptomic analysis, an RNA-based approach, addresses these shortcomings by capturing functional transcripts that are actively expressed in living microbes. STUDY DESIGN, SIZE, DURATION: This cross-sectional study consisted of forty-nine reproductive-aged women (27–42 years old) who were receiving ART. By simultaneously analysing the microbial composition and gene expression within female reproductive tract samples, we sought to provide a more comprehensive understanding of the microbiota and functional potential of these samples. PARTICIPANTS/MATERIALS, SETTING, METHODS: Vaginal swabs, endometrial brushing, and endometrial biopsy samples were collected from 49 participants during the mid-secretory phase of their menstrual cycle, 6–9 days after the luteinizing hormone surge for parallel 16S rRNA gene sequencing and meta-transcriptome analyses. For DNA-based analysis, 16S rRNA gene V3-V4 regions were sequenced. For RNA-based total RNA was extracted followed by ribosomal RNA depletion. Strand-specific total RNA sequencing libraries were prepared and sequenced. Taxonomy was assigned by using Kraken2 (v2.2.1), Bracken (v2.7). MAIN RESULTS AND THE ROLE OF CHANCE: Our findings suggest that in low-microbial-biomass environments such as the endometrium, the correlation between 16S rRNA gene sequencing and meta-transcriptomics is relatively weak. This highlights the limitations of microbial analysis of low-microbial-biomass samples. Alternatively, microbial functions and genome activity may be tissue-specific and dependent on the host tissue environment. Moreover, RNA-based analysis provides higher resolution in detecting certain pathogens, even within the endometrium. LARGE SCALE DATA: The data presented in the study are deposited in the NCBI SRA Database, accession number PRJNA1247240. LIMITATIONS, REASONS FOR CAUTION: High levels of host RNA and the low abundance of microbial reads in the endometrium complicate microbial identification. Our findings indicate that RNA-seq enables precise profiling of the vaginal microbiome and, in cases of dysbiosis, reveals higher pathogen activity than DNA-based approaches. However, the limited sample size restricts the generalization of these conclusions. WIDER IMPLICATIONS OF THE FINDINGS: Contrary to the general belief of the dominance of Lactobacillus in the human endometrium, our study suggests that the endometrial microenvironment may be harbouring DNA fragments and/or cells of lactobacilli originating from the lower reproductive tract. Our study results indicate a need to re-consider/re-analyse the endometrial microbiome in health and disease. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the projects Endo-Map PID2021-127280OB-I00, ROSY CNS2022-135999 and ENDORE SAF2017-87526-R funded by MICIU/AEI/10.13039/501100011033 and by FEDER, EU. This work was also supported by the Estonian Research Council grants (PSG1082 and PRG1076), Swedish Research Council grant no. 2024-02530 and Novo Nordisk Foundation grant no. NNF24OC0092384. Additionally, A.S.L and I.P.P acknowledge Becas Fundación Ramón Areces para Estudios Postdoctorales—Convocatorias XXXV and XXXVI, para Ampliación de Estudios en el Extranjero en Ciencias de la Vida y de la Materia. A.S. is supported by Horizon Europe (NESTOR, grant no. 101120075) and the Ministry of Education and Research Centres of Excellence grant TK214 name of CoE. All the authors declare no conflict of interest.
- 6 January 2026
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (1)
Top Cited PapersOpen AccessComprehensive 16S rRNA gene sequencing and meta-transcriptomic analyses of the female reproductive tract microbiota: two molecular profiles with different messages
STUDY QUESTION: Does the analysis of endometrial microbes provide the same information when using DNA or RNA sequencing-based techniques? SUMMARY ANSWER: DNA vs. RNA-based microbial analysis techniques demonstrated significant microbial compositional differences and lack of transcriptionally active Lactobacilli in the endometrium. WHAT IS KNOWN ALREADY: Our understanding of the endometrial microbiome is primarily based on DNA-based 16S rRNA gene profiling, but DNA detection does not imply the presence of living microbes. While this method is cost-effective and widely used, it has notable limitations, including the underestimation of microbial diversity, abundance, and functionality, as well as limited species-level resolution. While the microbiome reflects DNA-based characterisation, the microbiota more precisely captures metabolically active communities. In this context, meta-transcriptomic analysis, an RNA-based approach, addresses these shortcomings by capturing functional transcripts that are actively expressed in living microbes. STUDY DESIGN, SIZE, DURATION: This cross-sectional study consisted of forty-nine reproductive-aged women (27–42 years old) who were receiving ART. By simultaneously analysing the microbial composition and gene expression within female reproductive tract samples, we sought to provide a more comprehensive understanding of the microbiota and functional potential of these samples. PARTICIPANTS/MATERIALS, SETTING, METHODS: Vaginal swabs, endometrial brushing, and endometrial biopsy samples were collected from 49 participants during the mid-secretory phase of their menstrual cycle, 6–9 days after the luteinizing hormone surge for parallel 16S rRNA gene sequencing and meta-transcriptome analyses. For DNA-based analysis, 16S rRNA gene V3-V4 regions were sequenced. For RNA-based total RNA was extracted followed by ribosomal RNA depletion. Strand-specific total RNA sequencing libraries were prepared and sequenced. Taxonomy was assigned by using Kraken2 (v2.2.1), Bracken (v2.7). MAIN RESULTS AND THE ROLE OF CHANCE: Our findings suggest that in low-microbial-biomass environments such as the endometrium, the correlation between 16S rRNA gene sequencing and meta-transcriptomics is relatively weak. This highlights the limitations of microbial analysis of low-microbial-biomass samples. Alternatively, microbial functions and genome activity may be tissue-specific and dependent on the host tissue environment. Moreover, RNA-based analysis provides higher resolution in detecting certain pathogens, even within the endometrium. LARGE SCALE DATA: The data presented in the study are deposited in the NCBI SRA Database, accession number PRJNA1247240. LIMITATIONS, REASONS FOR CAUTION: High levels of host RNA and the low abundance of microbial reads in the endometrium complicate microbial identification. Our findings indicate that RNA-seq enables precise profiling of the vaginal microbiome and, in cases of dysbiosis, reveals higher pathogen activity than DNA-based approaches. However, the limited sample size restricts the generalization of these conclusions. WIDER IMPLICATIONS OF THE FINDINGS: Contrary to the general belief of the dominance of Lactobacillus in the human endometrium, our study suggests that the endometrial microenvironment may be harbouring DNA fragments and/or cells of lactobacilli originating from the lower reproductive tract. Our study results indicate a need to re-consider/re-analyse the endometrial microbiome in health and disease. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the projects Endo-Map PID2021-127280OB-I00, ROSY CNS2022-135999 and ENDORE SAF2017-87526-R funded by MICIU/AEI/10.13039/501100011033 and by FEDER, EU. This work was also supported by the Estonian Research Council grants (PSG1082 and PRG1076), Swedish Research Council grant no. 2024-02530 and Novo Nordisk Foundation grant no. NNF24OC0092384. Additionally, A.S.L and I.P.P acknowledge Becas Fundación Ramón Areces para Estudios Postdoctorales—Convocatorias XXXV and XXXVI, para Ampliación de Estudios en el Extranjero en Ciencias de la Vida y de la Materia. A.S. is supported by Horizon Europe (NESTOR, grant no. 101120075) and the Ministry of Education and Research Centres of Excellence grant TK214 name of CoE. All the authors declare no conflict of interest.
- Open Access
- 1 April 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 51 (3) , 104988
Assessing the ovarian microbiome: lack of a distinguishable microbial signature beyond contamination
- 1 April 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 51 (3) , 104988
Open AccessAssessing the ovarian microbiome: lack of a distinguishable microbial signature beyond contamination
- Open Access
Comprehensive 16S rRNA gene sequencing and meta-transcriptomic analyses in female reproductive tract microbiota: Two molecular profiles with different messages
In recent years, high-throughput sequencing technologies have revolutionised reproductive microbiome research. Our understanding of the endometrial microbiome is primarily based on DNA-based 16S rRNA gene profiling, but DNA detection does not imply alive microbe presence. While this method is cost-effective and widely used, it has notable limitations, including the underestimation of microbial diversity, abundance, and functionality, as well as limited species-level resolution. Meta-transcriptomic analysis, an RNA-based approach, addresses these shortcomings by capturing functional transcripts that are actively expressed in living microbes. This study aims to characterize the endometrial microbiota through a dual approach, by integrating 16S rRNA gene sequencing and meta-transcriptomic analyses. By simultaneously analysing microbial composition and gene expression within the female reproductive tract samples, we seek to provide a more comprehensive understanding of its microbiota and their functional potential. A total of 49 women, aged 27–42 years, were enrolled in the study. Vaginal swabs, endometrial brushings, and endometrial biopsy samples were collected from each participant during the mid-secretory menstrual cycle phase, 6-9 days post luteinizing hormone surge. Our findings suggest that in low-microbial-biomass environments like the endometrium, the correlation between 16S rRNA gene sequencing and meta-transcriptomics is relatively weak. This highlights the limitations of microbial analysis of low-microbial-biomass samples. Alternatively, it suggests that microbial functions and genome activity are tissue-specific and dependent on the host tissue environment. Moreover, RNA-based analysis provides higher resolution in detecting certain pathogens, even within the endometrium. In conclusion, our study underscores the need to integrate genomic and transcriptomic data in microbiota studies to better elucidate critical and health-related microbiota-host interactions.
Open AccessComprehensive 16S rRNA gene sequencing and meta-transcriptomic analyses in female reproductive tract microbiota: Two molecular profiles with different messages
In recent years, high-throughput sequencing technologies have revolutionised reproductive microbiome research. Our understanding of the endometrial microbiome is primarily based on DNA-based 16S rRNA gene profiling, but DNA detection does not imply alive microbe presence. While this method is cost-effective and widely used, it has notable limitations, including the underestimation of microbial diversity, abundance, and functionality, as well as limited species-level resolution. Meta-transcriptomic analysis, an RNA-based approach, addresses these shortcomings by capturing functional transcripts that are actively expressed in living microbes. This study aims to characterize the endometrial microbiota through a dual approach, by integrating 16S rRNA gene sequencing and meta-transcriptomic analyses. By simultaneously analysing microbial composition and gene expression within the female reproductive tract samples, we seek to provide a more comprehensive understanding of its microbiota and their functional potential. A total of 49 women, aged 27–42 years, were enrolled in the study. Vaginal swabs, endometrial brushings, and endometrial biopsy samples were collected from each participant during the mid-secretory menstrual cycle phase, 6-9 days post luteinizing hormone surge. Our findings suggest that in low-microbial-biomass environments like the endometrium, the correlation between 16S rRNA gene sequencing and meta-transcriptomics is relatively weak. This highlights the limitations of microbial analysis of low-microbial-biomass samples. Alternatively, it suggests that microbial functions and genome activity are tissue-specific and dependent on the host tissue environment. Moreover, RNA-based analysis provides higher resolution in detecting certain pathogens, even within the endometrium. In conclusion, our study underscores the need to integrate genomic and transcriptomic data in microbiota studies to better elucidate critical and health-related microbiota-host interactions.
- Open Access
- 24 February 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2025 (2) , hoaf010
Multi-omics analysis of uterine fluid extracellular vesicles reveals a resemblance with endometrial tissue across the menstrual cycle: biological and translational insights
STUDY QUESTION: Does the molecular composition of uterine fluid extracellular vesicles (UF-EVs) reflect endometrial tissue changes across the menstrual cycle? SUMMARY ANSWER: Concordance between endometrial tissue and UF-EVs exists on miRNA and mRNA levels along the menstrual cycle phases and UF-EV surface proteomic signatures suggest EVs originate from several major endometrial cell populations. WHAT IS KNOWN ALREADY: The clinical value of endometrial receptivity testing is restricted by invasiveness and the use of only one omics level of input. There is promising evidence that UF-EVs can reflect changes in mid-secretory endometrium, highlighting the potential to establish endometrial receptivity testing right before embryo transfer. However, the dynamic changes of UF-EVs molecular cargo have not been directly compared to endometrial tissue on multiple omics levels. STUDY DESIGN, SIZE, DURATION: This cross-sectional study included fertile women from four menstrual cycle phases: proliferative and early-, mid-, and late-secretory phases. In total, 26 paired samples of UF and endometrial tissue were collected. mRNA and miRNA were sequenced, and differential analysis was performed on consecutive phases. UF-EVs were profiled for various protein surface markers associated with different cell types. EVs from epithelial endometrial organoid-conditioned culture media were used as a reference of pure epithelial endometrial EVs. PARTICIPANTS/MATERIALS, SETTING, METHODS: Paired UF and endometrial tissue samples were collected from 26 fertile, reproductive-age women. EV isolation from UF was validated using electron microscopy and western blotting, and particle numbers were measured by nanoparticle tracking analysis. The transcriptome and miRNome of UF-EVs and endometrial tissue were sequenced, and differential expression analysis was conducted on consecutive phases of the menstrual cycle. Bead-based EV flow cytometry targeting 37 surface protein markers was used to characterize EVs from UF and endometrial organoids. MAIN RESULTS AND THE ROLE OF CHANCE: Surface proteome analysis revealed that UF-EVs from the mid-secretory phase had significantly increased expression of natural killer cell marker CD56 (P < 0.005), pan-leukocyte marker CD45 (P < 0.005), pan-T-cell marker CD3 (P < 0.005), and coagulation-related protein CD142 (P < 0.005) compared to those from the proliferative phase, whereas markers associated with endometrial epithelial cells (CD29, CD133, and CD326) did not significantly change across the menstrual cycle. Transcriptomic analysis highlighted differential expression of histone and metallothionein genes that correlated between paired UF-EVs and endometrial tissues in each tested menstrual cycle phase. Principal component analysis of miRNomes of paired UF-EVs and endometrial tissue samples resulted in similar clustering patterns, where mid- and late-secretory samples clustered closely, and proliferative and early-secretory phase samples clustered separately. Half of the differentially expressed miRNAs in each phase in UF-EVs were also differentially expressed in the endometrium. Importantly, nine mid-secretory phase UF-EV DE miRNAs were identified, five of which were common between UF-EVs and endometrial biopsies, including hsa-miR-30d-5p and hsa-miR-200b-3p, both of which were previously implicated in implantation. Notably, three of the nine miRNAs, hsa-miR-200b-3p, hsa-miR-141-3p, and hsa-miR-200a-3p, were predicted to regulate mRNAs in the endometrial tissue and the pre-implantation embryo trophectoderm. LARGE SCALE DATA: N/A LIMITATIONS, REASONS FOR CAUTION: The clinical dating of the menstrual cycle phase is based on the first day of menstruation and the time of the LH peak, which does not exclude the possibility that the expected endometrial phase was not reached. The wider limitation of our study is the lack of standardized procedures for collecting UF samples in gynaecological practice, which could challenge the replication of our findings. WIDER IMPLICATIONS OF THE FINDINGS: Evidence that UF-EVs reflect endometrial phases of menstrual cycle supports the use of UF-EVs in endometrial receptivity testing. Additionally, further studies of UF-EVs in endometrial pathologies could be beneficial for diagnostics, considering that more invasive tissue biopsies only reflect the biopsy site and not the full endometrium. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the European Regional Development Fund Enterprise Estonia’s Applied Research Program under the grant agreement number 2014-2020.4.02.21-0398 (EVREM), the Estonian Research Council (grant nos. PRG1076 and PSG1082), the Horizon Europe NESTOR grant (grant no. 101120075) of the European Commission, the Swedish Research Council (grant no. 2024-02530), the Novo Nordisk Fonden (grant no. NNF24OC0092384), and the National Recovery and Resilience Plan of the Republic of Bulgaria, project number BG-RRP-2.004-0001-C01. A.S.L. received funding from the Becas Fundación Ramón Areces para Estudios Postdoctorales. All the authors declare no conflict of interest.
- 24 February 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2025 (2) , hoaf010
Open AccessMulti-omics analysis of uterine fluid extracellular vesicles reveals a resemblance with endometrial tissue across the menstrual cycle: biological and translational insights
STUDY QUESTION: Does the molecular composition of uterine fluid extracellular vesicles (UF-EVs) reflect endometrial tissue changes across the menstrual cycle? SUMMARY ANSWER: Concordance between endometrial tissue and UF-EVs exists on miRNA and mRNA levels along the menstrual cycle phases and UF-EV surface proteomic signatures suggest EVs originate from several major endometrial cell populations. WHAT IS KNOWN ALREADY: The clinical value of endometrial receptivity testing is restricted by invasiveness and the use of only one omics level of input. There is promising evidence that UF-EVs can reflect changes in mid-secretory endometrium, highlighting the potential to establish endometrial receptivity testing right before embryo transfer. However, the dynamic changes of UF-EVs molecular cargo have not been directly compared to endometrial tissue on multiple omics levels. STUDY DESIGN, SIZE, DURATION: This cross-sectional study included fertile women from four menstrual cycle phases: proliferative and early-, mid-, and late-secretory phases. In total, 26 paired samples of UF and endometrial tissue were collected. mRNA and miRNA were sequenced, and differential analysis was performed on consecutive phases. UF-EVs were profiled for various protein surface markers associated with different cell types. EVs from epithelial endometrial organoid-conditioned culture media were used as a reference of pure epithelial endometrial EVs. PARTICIPANTS/MATERIALS, SETTING, METHODS: Paired UF and endometrial tissue samples were collected from 26 fertile, reproductive-age women. EV isolation from UF was validated using electron microscopy and western blotting, and particle numbers were measured by nanoparticle tracking analysis. The transcriptome and miRNome of UF-EVs and endometrial tissue were sequenced, and differential expression analysis was conducted on consecutive phases of the menstrual cycle. Bead-based EV flow cytometry targeting 37 surface protein markers was used to characterize EVs from UF and endometrial organoids. MAIN RESULTS AND THE ROLE OF CHANCE: Surface proteome analysis revealed that UF-EVs from the mid-secretory phase had significantly increased expression of natural killer cell marker CD56 (P < 0.005), pan-leukocyte marker CD45 (P < 0.005), pan-T-cell marker CD3 (P < 0.005), and coagulation-related protein CD142 (P < 0.005) compared to those from the proliferative phase, whereas markers associated with endometrial epithelial cells (CD29, CD133, and CD326) did not significantly change across the menstrual cycle. Transcriptomic analysis highlighted differential expression of histone and metallothionein genes that correlated between paired UF-EVs and endometrial tissues in each tested menstrual cycle phase. Principal component analysis of miRNomes of paired UF-EVs and endometrial tissue samples resulted in similar clustering patterns, where mid- and late-secretory samples clustered closely, and proliferative and early-secretory phase samples clustered separately. Half of the differentially expressed miRNAs in each phase in UF-EVs were also differentially expressed in the endometrium. Importantly, nine mid-secretory phase UF-EV DE miRNAs were identified, five of which were common between UF-EVs and endometrial biopsies, including hsa-miR-30d-5p and hsa-miR-200b-3p, both of which were previously implicated in implantation. Notably, three of the nine miRNAs, hsa-miR-200b-3p, hsa-miR-141-3p, and hsa-miR-200a-3p, were predicted to regulate mRNAs in the endometrial tissue and the pre-implantation embryo trophectoderm. LARGE SCALE DATA: N/A LIMITATIONS, REASONS FOR CAUTION: The clinical dating of the menstrual cycle phase is based on the first day of menstruation and the time of the LH peak, which does not exclude the possibility that the expected endometrial phase was not reached. The wider limitation of our study is the lack of standardized procedures for collecting UF samples in gynaecological practice, which could challenge the replication of our findings. WIDER IMPLICATIONS OF THE FINDINGS: Evidence that UF-EVs reflect endometrial phases of menstrual cycle supports the use of UF-EVs in endometrial receptivity testing. Additionally, further studies of UF-EVs in endometrial pathologies could be beneficial for diagnostics, considering that more invasive tissue biopsies only reflect the biopsy site and not the full endometrium. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the European Regional Development Fund Enterprise Estonia’s Applied Research Program under the grant agreement number 2014-2020.4.02.21-0398 (EVREM), the Estonian Research Council (grant nos. PRG1076 and PSG1082), the Horizon Europe NESTOR grant (grant no. 101120075) of the European Commission, the Swedish Research Council (grant no. 2024-02530), the Novo Nordisk Fonden (grant no. NNF24OC0092384), and the National Recovery and Resilience Plan of the Republic of Bulgaria, project number BG-RRP-2.004-0001-C01. A.S.L. received funding from the Becas Fundación Ramón Areces para Estudios Postdoctorales. All the authors declare no conflict of interest.
- Open Access
- 4 January 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 1-10
Uterus didelphys: the first case report on molecular profiling of endometrial tissue from both uterine cavities
Background: A didelphic uterus represents a unique and infrequent congenital condition in which a woman possesses two distinct uteri, each with its own cervix. This anomaly arises due to partial or incomplete merging of the Müllerian ducts during the developmental stages in the womb. Accounting for uterine malformations, a didelphic uterus is a relatively rare condition, affecting approximately 0.5–2% of the population and is considered one of the more uncommon types of uterine abnormalities. Methods: This case report aims to study the physical separation in uterine didelphys and its impact on endometrial microbiome and inflammation, and the patterns of endometrial receptivity observed. Results: Endometrial receptivity analyses revealed a similar receptive state in both uteri, both in the early receptive phase. Differential markers of chronic endometritis, including CD138, and MUM1-positive cells, were observed when comparing endometrial biopsies from both uteri. The right uterus exhibited a higher prevalence of these positive cells. Regarding the microbiome, significant differences were found between the uteri, notably in the right uterus, a clear non-dominance of lactobacilli and the presence of genera such as Staphylococcus, Streptococcus, and Acinetobacter. Additionally, the right uterus presented a less ‘favourable’ microenvironment, a characteristic that was also reflected in the right cervix; both sites presenting less lactobacilli than the left side samples. A distinct metabolomic signature associated with the physical separation of the uteri contributed to the differences in endometrial milieu. Conclusions: Our study revealed that physical separation, among other factors in uterus didelphys, affects the endometrial microbiome, metabolome, and inflammatory state, with significant microbiome variation observed between the uteri, although similar endometrial receptivity patterns were noted.
- 4 January 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 1-10
Open AccessUterus didelphys: the first case report on molecular profiling of endometrial tissue from both uterine cavities
Background: A didelphic uterus represents a unique and infrequent congenital condition in which a woman possesses two distinct uteri, each with its own cervix. This anomaly arises due to partial or incomplete merging of the Müllerian ducts during the developmental stages in the womb. Accounting for uterine malformations, a didelphic uterus is a relatively rare condition, affecting approximately 0.5–2% of the population and is considered one of the more uncommon types of uterine abnormalities. Methods: This case report aims to study the physical separation in uterine didelphys and its impact on endometrial microbiome and inflammation, and the patterns of endometrial receptivity observed. Results: Endometrial receptivity analyses revealed a similar receptive state in both uteri, both in the early receptive phase. Differential markers of chronic endometritis, including CD138, and MUM1-positive cells, were observed when comparing endometrial biopsies from both uteri. The right uterus exhibited a higher prevalence of these positive cells. Regarding the microbiome, significant differences were found between the uteri, notably in the right uterus, a clear non-dominance of lactobacilli and the presence of genera such as Staphylococcus, Streptococcus, and Acinetobacter. Additionally, the right uterus presented a less ‘favourable’ microenvironment, a characteristic that was also reflected in the right cervix; both sites presenting less lactobacilli than the left side samples. A distinct metabolomic signature associated with the physical separation of the uteri contributed to the differences in endometrial milieu. Conclusions: Our study revealed that physical separation, among other factors in uterus didelphys, affects the endometrial microbiome, metabolome, and inflammatory state, with significant microbiome variation observed between the uteri, although similar endometrial receptivity patterns were noted.